• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
 

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

on

  • 221 views

 

Statistics

Views

Total Views
221
Views on SlideShare
221
Embed Views
0

Actions

Likes
2
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Document Transcript

    • Orthobiologics Market Outlook in BRICS (Brazil, Russia, India,China, South Africa) to 2018Report Details:Published:August 2012No. of Pages: 207Price: Single User License – US$2500Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018SummaryGlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China,South Africa) to 2018” provides key market data on the Orthobiologics market in the BRICScountries. The report provides value ($m), volume (units) and average price ($) data for eachsegment and sub-segment within four market categories – Bone Graft Substitutes, BoneAllografts, Viscosupplementation and Bone Growth Stimulators. The report also provides companyshares and distribution shares data for the overall Orthobiologics market in each of theaforementioned countries. The report is also supplemented with global corporate-level profiles ofthe key market participants with information on key developments, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.The emerging economies, comprising China, India, Brazil, Russia and South Africa, with asignificantly large pool of under-served patients, represent the next big opportunity for the leadingmedical equipment and devices manufacturers. China remains the world’s most populous countryand is consequently home to a large patient base. The country is home to more than 120 millionpeople who are aged 65 or older—a population in continuous need of medical care. India, thesecond most populous country globally, is home to 1.2 billion people, approximately 5% of whichare aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China,making it the most populous country in the world. As the population continues to grow and peoplecontinue to age, the underlying demand for healthcare is also expected to increase.Scope- Market size data for Orthobiologics market categories – Bone Graft Substitutes, Bone Allografts,
    • Viscosupplementation and Bone Growth Stimulators.- Annualized market revenues ($m), volume (units) and average price ($) data for each of thesegments and sub-segments within the four market categories. Data from 2004 to 2011, forecastforward for seven years to 2018.- 2011 company shares and distribution shares data for the overall Orthobiologics market in eachof the aforementioned countries.- Global corporate-level profiles of key companies operating within the Orthobiologics market inBRICS.- Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Medtronic, Inc.,Baxter International Inc., Biomet, Inc., Orthofix International N.V., Smith & Nephew Plc, GlobusMedical, Inc., Wright Medical Group, Inc., Stryker Corporation, DJO Finance LLC, FerringInternational Center S.A., Seikagaku Corporation, Anika Therapeutics, Inc. and Alphatec Holdings,Inc..Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Orthobiologics competitivelandscape in BRICS.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/190152-orthobiologics-market-outlook-in-brics-brazil-russia-india-china-south-africa-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 81.2 List of Figures 122 Introduction 152.1 What is This Report About? 153 Orthobiologics in BRICS 163.1 Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 163.2 Orthobiologics, BRICS, Company share (2010-2011) 214 Orthobiologics In Brazil 234.1 Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 234.2 Bone Graft Substitutes In Brazil 28
    • 4.2.1 Bone Graft Substitutes, Brazil, Overall Revenue (2004-2018) 284.2.2 Bone Graft Substitutes, Brazil, Overall Volume (2004-2018) 324.2.3 Bone Graft Substitutes, Brazil, Average Price (2004-2018) 354.3 Bone Allografts In Brazil 364.3.1 Bone Allografts, Brazil, Overall Revenue (2004-2018) 364.4 Viscosupplementation In Brazil 384.4.1 Viscosupplementation, Brazil, Overall Revenue (2004-2018) 384.4.2 Viscosupplementation, Brazil, Overall Volume (2004-2018) 404.4.3 Viscosupplementation, Brazil, Average Price (2004-2018) 424.5 Bone Growth Stimulators In Brazil 434.5.1 Bone Growth Stimulators, Brazil, Overall Revenue (2004-2018) 434.5.2 Bone Growth Stimulators, Brazil, Overall Volume (2004-2018) 454.5.3 Bone Growth Stimulators, Brazil, Average Price (2004-2018) 474.6 Orthobiologics, Brazil, Distribution Share (2010-2011) 484.7 Orthobiologics, Brazil, Company Share (2010-2011) 495 Orthobiologics In Russian Federation 515.1 Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 515.2 Bone Graft Substitutes In Russian Federation 575.2.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2004-2018) 575.2.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2004-2018) 615.2.3 Bone Graft Substitutes, Russian Federation, Average Price (2004-2018) 655.3 Bone Allografts In Russian Federation 665.3.1 Bone Allografts, Russian Federation, Overall Revenue (2004-2018) 665.4 Bone Growth Stimulators In Russian Federation 685.4.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2004-2018) 685.4.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2004-2018) 715.4.3 Bone Growth Stimulators, Russian Federation, Average Price (2004-2018) 735.5 Viscosupplementation In Russian Federation 745.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2004-2018) 745.5.2 Viscosupplementation, Russian Federation, Overall Volume (2004-2018) 775.5.3 Viscosupplementation, Russian Federation, Average Price (2004-2018) 795.6 Orthobiologics, Russian Federation, Distribution Share (2010-2011) 805.7 Orthobiologics, Russian Federation, Company Share (2010-2011) 816 Orthobiologics In India 836.1 Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 836.2 Bone Graft Substitutes In India 886.2.1 Bone Graft Substitutes, India, Overall Revenue (2004-2018) 886.2.2 Bone Graft Substitutes, India, Overall Volume (2004-2018) 926.2.3 Bone Graft Substitutes, India, Average Price (2004-2018) 956.3 Bone Allografts In India 966.3.1 Bone Allografts, India, Overall Revenue (2004-2018) 966.4 Viscosupplementation In India 98
    • 6.4.1 Viscosupplementation, India, Overall Revenue (2004-2018) 986.4.2 Viscosupplementation, India, Overall Volume (2004-2018) 1006.4.3 Viscosupplementation, India, Average Price (2004-2018) 1026.5 Bone Growth Stimulators In India 1036.5.1 Bone Growth Stimulators, India, Overall Revenue (2004-2018) 1036.5.2 Bone Growth Stimulators, India, Overall Volume (2004-2018) 1056.5.3 Bone Growth Stimulators, India, Average Price (2004-2018) 1076.6 Orthobiologics, India, Distribution Share (2010-2011) 1086.7 Orthobiologics, India, Company Share (2010-2011) 1097 Orthobiologics In China 1117.1 Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 1117.2 Bone Graft Substitutes In China 1167.2.1 Bone Graft Substitutes, China, Overall Revenue (2004-2018) 1167.2.2 Bone Graft Substitutes, China, Overall Volume (2004-2018) 1207.2.3 Bone Graft Substitutes, China, Average Price (2004-2018) 1237.3 Bone Allografts In China 1247.3.1 Bone Allografts, China, Overall Revenue (2004-2018) 1247.4 Viscosupplementation In China 1267.4.1 Viscosupplementation, China, Overall Revenue (2004-2018) 1267.4.2 Viscosupplementation, China, Overall Volume (2004-2018) 1287.4.3 Viscosupplementation, China, Average Price (2004-2018) 1307.5 Bone Growth Stimulators In China 1317.5.1 Bone Growth Stimulators, China, Overall Revenue (2004-2018) 1317.5.2 Bone Growth Stimulators, China, Overall Volume (2004-2018) 1337.5.3 Bone Growth Stimulators, China, Average Price (2004-2018) 1357.6 Orthobiologics, China, Distribution Share (2010-2011) 1367.7 Orthobiologics, China, Company Share (2010-2011) 1378 Orthobiologics In South Africa 1398.1 Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 1398.2 Bone Graft Substitutes In South Africa 1458.2.1 Bone Graft Substitutes, South Africa, Overall Revenue (2004-2018) 1458.2.2 Bone Graft Substitutes, South Africa, Overall Volume (2004-2018) 1498.2.3 Bone Graft Substitutes, South Africa, Average Price (2004-2018) 1538.3 Bone Allografts In South Africa 1548.3.1 Bone Allografts, South Africa, Overall Revenue (2004-2018) 1548.4 Viscosupplementation In South Africa 1568.4.1 Viscosupplementation, South Africa, Overall Revenue (2004-2018) 1568.4.2 Viscosupplementation, South Africa, Overall Volume (2004-2018) 1588.4.3 Viscosupplementation, South Africa, Average Price (2004-2018) 1608.5 Bone Growth Stimulators In South Africa 1618.5.1 Bone Growth Stimulators, South Africa, Overall Revenue (2004-2018) 1618.5.2 Bone Growth Stimulators, South Africa, Overall Volume (2004-2018) 165
    • 8.5.3 Bone Growth Stimulators, South Africa, Average Price (2004-2018) 1678.6 Orthobiologics, South Africa, Distribution Share (2010-2011) 1688.7 Orthobiologics, South Africa, Company Share (2010-2011) 1699 Overview of Key Companies in BRICS Orthobiologics Market 1719.1 DePuy, Inc. 1719.1.1 Company Overview 1719.1.2 Share in the BRICS Orthobiologics Market 1729.2 Genzyme Corporation 1739.2.1 Company Overview 1739.2.2 Share in the BRICS Orthobiologics Market 1749.3 Synthes, Inc. 1759.3.1 Company Overview 1759.3.2 Share in the BRICS Orthobiologics Market 1769.4 Medtronic, Inc. 1779.4.1 Company Overview 1779.4.2 Share in the BRICS Orthobiologics Market 1789.5 Baxter International Inc. 1799.5.1 Company Overview 1799.5.2 Share in the BRICS Orthobiologics Market 1809.6 Biomet, Inc. 1819.6.1 Company Overview 1819.6.2 Share in the BRICS Orthobiologics Market 1829.7 Orthofix International N.V. 1839.7.1 Company Overview 1839.7.2 Share in the BRICS Orthobiologics Market 1849.8 Smith & Nephew Plc 1859.8.1 Company Overview 1859.8.2 Share in the BRICS Orthobiologics Market 1869.9 Globus Medical, Inc. 1879.9.1 Company Overview 1879.10 Wright Medical Group, Inc. 1889.10.1 Company Overview 1889.10.2 Share in the BRICS Orthobiologics Market 1899.11 Stryker Corporation 1909.11.1 Company Overview 1909.11.2 Share in the BRICS Orthobiologics Market 1919.12 DJO Finance LLC 1929.12.1 Company Overview 1929.12.2 Share in the BRICS Orthobiologics Market 1939.13 Ferring International Center S.A. 1949.13.1 Company Overview 1949.13.2 Share in the BRICS Orthobiologics Market 195
    • 9.14 Seikagaku Corporation 1969.14.1 Company Overview 1969.15 Anika Therapeutics, Inc. 1979.15.1 Company Overview 1979.15.2 Share in the BRICS Orthobiologics Market 1989.16 Alphatec Holdings, Inc. 1999.16.1 Company Overview 1999.16.2 Share in the BRICS Orthobiologics Market 2009.17 NuVasive, Inc. 2019.17.1 Company Overview 20110 Appendix 20210.1 Definitions of Markets Covered in the Report 20310.1.1 Orthobiologics 20310.2 Research Methodology 20410.3 Secondary Research 20410.4 Primary Research 20510.5 Models 20510.6 Forecasts 20610.7 Expert Panels 20610.8 GlobalData Consulting 20610.9 Currency Conversion 20710.10 Contact Us 20710.11 Disclaimer 2071.1 List of TablesTable 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16Table 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18Table 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20Table 4: Orthobiologics, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 22Table 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23Table 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25Table 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27Table 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 29Table 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast,2011-2018 31Table 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 33Table 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34Table 12: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2004-2011 35Table 13: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2011-2018 35Table 14: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36Table 15: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37
    • Table 16: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38Table 17: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39Table 18: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40Table 19: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41Table 20: Viscosupplementation, Brazil, Average Price ($), Historic, 2004-2011 42Table 21: Viscosupplementation, Brazil, Average Price ($), Forecast, 2011-2018 42Table 22: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43Table 23: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-201844Table 24: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45Table 25: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46Table 26: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2004-2011 47Table 27: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2011-2018 47Table 28: Orthobiologics, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-201148Table 29: Orthobiologics, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 50Table 30: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-201852Table 31: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic,2004-2011 54Table 32: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast,2011-2018 56Table 33: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant,Historic, 2004-2011 58Table 34: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant,Forecast, 2011-2018 60Table 35: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 62Table 36: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast,2011-2018 64Table 37: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2004-2011 65Table 38: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2011-2018 65Table 39: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-201166Table 40: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 67Table 41: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic,2004-2011 69Table 42: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast,2011-2018 70Table 43: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71Table 44: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72
    • Table 45: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2004-201173Table 46: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2011-201873Table 47: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic,2004-2011 75Table 48: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast,2011-2018 76Table 49: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77Table 50: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78Table 51: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2004-2011 79Table 52: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2011-2018 79Table 53: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), USDConstant, 2010-2011 80Table 54: Orthobiologics, Russian Federation, Company Share by Revenue ($m), USD Constant,2010-2011 82Table 55: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83Table 56: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 85Table 57: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 87Table 58: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic,2004-2011 89Table 59: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast,2011-2018 91Table 60: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 93Table 61: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94Table 62: Bone Graft Substitutes, India, Average Price ($), Historic, 2004-2011 95Table 63: Bone Graft Substitutes, India, Average Price ($), Forecast, 2011-2018 95Table 64: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96Table 65: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97Table 66: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98Table 67: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99Table 68: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100Table 69: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101Table 70: Viscosupplementation, India, Average Price ($), Historic, 2004-2011 102Table 71: Viscosupplementation, India, Average Price ($), Forecast, 2011-2018 102Table 72: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103Table 73: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018104Table 74: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105Table 75: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106Table 76: Bone Growth Stimulators, India, Average Price ($), Historic, 2004-2011 107Table 77: Bone Growth Stimulators, India, Average Price ($), Forecast, 2011-2018 107
    • Table 78: Orthobiologics, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011108Table 79: Orthobiologics, India, Company Share by Revenue ($m), USD Constant, 2010-2011 110Table 80: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111Table 81: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 113Table 82: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 115Table 83: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic,2004-2011 117Table 84: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast,2011-2018 119Table 85: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 121Table 86: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122Table 87: Bone Graft Substitutes, China, Average Price ($), Historic, 2004-2011 123Table 88: Bone Graft Substitutes, China, Average Price ($), Forecast, 2011-2018 123Table 89: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124Table 90: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125Table 91: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126Table 92: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127Table 93: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128Table 94: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129Table 95: Viscosupplementation, China, Average Price ($), Historic, 2004-2011 130Table 96: Viscosupplementation, China, Average Price ($), Forecast, 2011-2018 130Table 97: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011131Table 98: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018132Table 99: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133Table 100: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134Table 101: Bone Growth Stimulators, China, Average Price ($), Historic, 2004-2011 135Table 102: Bone Growth Stimulators, China, Average Price ($), Forecast, 2011-2018 135Table 103: Orthobiologics, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011136Table 104: Orthobiologics, China, Company Share by Revenue ($m), USD Constant, 2010-2011138Table 105: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 140Table 106: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 142Table 107: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 144Table 108: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant,Historic, 2004-2011 146Table 109: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant,
    • Forecast, 2011-2018 148Table 110: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011150Table 111: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 152Table 112: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2004-2011 153Table 113: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2011-2018 153Table 114: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154Table 115: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155Table 116: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 156Table 117: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 157Table 118: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158Table 119: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159Table 120: Viscosupplementation, South Africa, Average Price ($), Historic, 2004-2011 160Table 121: Viscosupplementation, South Africa, Average Price ($), Forecast, 2011-2018 160Table 122: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 162Table 123: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 164Table 124: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165Table 125: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166Table 126: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2004-2011 167Table 127: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2011-2018 167Table 128: Orthobiologics, South Africa, Distribution Share by Revenue ($m), USD Constant,2010-2011 168Table 129: Orthobiologics, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 170Table 130: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 172Table 131: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 174Table 132: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 176Table 133: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 178Table 134: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 180Table 135: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 182Table 136: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2011 184Table 137: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2011 186Table 138: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 187Table 139: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 189Table 140: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 191Table 141: DJO Finance LLC, Revenue ($m), BRICS Orthobiologics Market, 2011 193Table 142: Ferring International Center S.A., Revenue ($m), BRICS Orthobiologics Market, 2011
    • 195Table 143: Seikagaku Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 196Table 144: Anika Therapeutics, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 198Table 145: Alphatec Holdings, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 2001.2 List of FiguresFigure 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19Figure 4: Orthobiologics, BRICS, Company share (%), 2011 21Figure 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23Figure 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24Figure 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26Figure 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic,2004-2011 28Figure 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast,2011-2018 30Figure 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 32Figure 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34Figure 12: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36Figure 13: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37Figure 14: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38Figure 15: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39Figure 16: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40Figure 17: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41Figure 18: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43Figure 19: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-201844Figure 20: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45Figure 21: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46Figure 22: Orthobiologics, Brazil, Company Share (%), 2011 49Figure 23: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-201851Figure 24: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic,2004-2011 53Figure 25: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast,2011-2018 55Figure 26: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USDConstant, Historic, 2004-2011 57Figure 27: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USDConstant, Forecast, 2011-2018 59Figure 28: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic,
    • 2004-2011 61Figure 29: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast,2011-2018 63Figure 30: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 66Figure 31: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 67Figure 32: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic,2004-2011 68Figure 33: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant,Forecast, 2011-2018 70Figure 34: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71Figure 35: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72Figure 36: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic,2004-2011 74Figure 37: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast,2011-2018 76Figure 38: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77Figure 39: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78Figure 40: Orthobiologics, Russian Federation, Company Share (%), 2011 81Figure 41: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83Figure 42: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 84Figure 43: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 86Figure 44: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic,2004-2011 88Figure 45: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast,2011-2018 90Figure 46: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 92Figure 47: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94Figure 48: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96Figure 49: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97Figure 50: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98Figure 51: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99Figure 52: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100Figure 53: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101Figure 54: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011103Figure 55: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018104Figure 56: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105Figure 57: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106Figure 58: Orthobiologics, India, Company Share (%), 2011 109
    • Figure 59: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111Figure 60: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 112Figure 61: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 114Figure 62: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic,2004-2011 116Figure 63: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast,2011-2018 118Figure 64: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 120Figure 65: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122Figure 66: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124Figure 67: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125Figure 68: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126Figure 69: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127Figure 70: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128Figure 71: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129Figure 72: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011131Figure 73: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018132Figure 74: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133Figure 75: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134Figure 76: Orthobiologics, China, Company Share (%), 2011 137Figure 77: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139Figure 78: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 141Figure 79: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 143Figure 80: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant,Historic, 2004-2011 145Figure 81: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant,Forecast, 2011-2018 147Figure 82: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011149Figure 83: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018151Figure 84: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154Figure 85: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155Figure 86: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 156Figure 87: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 157Figure 88: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158
    • Figure 89: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159Figure 90: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 161Figure 91: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 163Figure 92: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165Figure 93: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166Figure 94: Orthobiologics, South Africa, Company Share (%), 2011 169Figure 95: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 172Figure 96: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2011 174Figure 97: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 176Figure 98: Medtronic, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 178Figure 99: Baxter International Inc., Company Share (%), BRICS Orthobiologics Market, 2011 180Figure 100: Biomet, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 182Figure 101: Orthofix International N.V., Company Share (%), BRICS Orthobiologics Market, 2011184Figure 102: Smith & Nephew Plc, Company Share (%), BRICS Orthobiologics Market, 2011 186Figure 103: Wright Medical Group, Inc., Company Share (%), BRICS Orthobiologics Market, 2011189Contact: sales@reportsandreports.com for more information.